Skip to main content
. 2021 Mar 30;7(1):37–40. doi: 10.4103/bc.bc_16_21

Figure 1.

Figure 1

This demonstrates the anti-inflammation-based therapeutic stroke targets. DRmQ robustly sequesters central and peripheral inflammation leading to a reduction in stroke-induced behavioral and histological deficits. These therapeutic effects may also be accomplished by similar anti-neuroinflammation strategies, such as stem cell transplantation and mitochondrial transfer